Skip to main navigation Skip to search Skip to main content

Role of BtK Inhibition in Disease Progression and Central Imaging in Preclinical Progressive MS

Project: Research

Project Details

StatusFinished
Effective start/end date12/29/20 → 12/28/22

Funding

  • Bristol Myers Squibb Company: $517,680.32